Clinical trials
Recruiting Observational Genetic Predisposition to Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| St. Jude Children's Research Hospital | 4 |
| University Hospital Tuebingen | 3 |
| Abramson Cancer Center at Penn Medicine | 2 |
| Institute of Cancer Research, United Kingdom | 2 |
| Magdi Yacoub Heart Foundation | 2 |
| Scientific Institute San Raffaele | 2 |
| Arbor Research Collaborative for Health | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Brigham and Women's Hospital | 1 |
| Children's Hospital of Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Predisposition to Disease | 40 |
| Prostatic Neoplasms | 5 |
| Genetic Diseases, Inborn | 4 |
| Cardiomyopathies | 3 |
| Neoplasms | 3 |
| Arrhythmias, Cardiac | 2 |
| Atrial Fibrillation | 2 |
| Autoimmune Diseases | 2 |
| Colorectal Neoplasms, Hereditary Nonpolyposis | 2 |
| Genetic Risk Score | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.